If the Boostrix® Tdap vaccine resulted in you or your child suffering from a Shoulder Injury Related to Vaccine Administration (SIRVA), your may be entitled to $250,000 from the Vaccine Injury Compensation Program.
Boostrix® is a Tdap vaccine that helps protect adults and teenagers against infections with tetanus, diphtheria, and pertussis (whooping cough).
How is Boostrix Given?
Boostrix is given as a single 0.5-mL injection in the deltoid muscle of the upper arm. Boostrix is recommended for teenagers who are 11 or 12 years old when they have completed the DTaP series of immunizations. Boostrix can also be given to adults who have never had a Tdap vaccine. It is also recommended for pregnant women.
Can Boostrix Cause SIRVA?
When a Boostrix vaccine is injected into the upper arm, it can potentially cause Shoulder Injury Related to Vaccine Administration (SIRVA), a devastating condition that can cause disability.
What is SIRVA?
SIRVA is an inflammatory reaction to the vaccine. It is believed to occur when the needle is injected too high or too deep into the shoulder bursa or other sensitive tissues, resulting in severe pain.
What is the Risk?
SIRVA causes severe shoulder pain, limited flexibility, poor strength, and muscle weakness that can make it difficult to lift heavy objects. It can result in a permanent disability with chronic shoulder pain.
Symptoms of SIRVA After Boostrix Vaccine
- Arm pain
- Shoulder pain
- Intense, stabbing pain
- Shoulder dysfunction
- Limited range of motion
- Lack of flexibility
It is very rare for Boostrix flu vaccines to cause SIRVA, but hundreds of people have developed serious shoulder injuries after vaccines. If you developed SIRVA from Boostrix, you may be eligible for up to $250,000 from the Vaccine Injury Compensation Program (VICP).
What is the VICP?
The Vaccine Injury Compensation Program (VICP) was created by Congress in the 1980s with a $0.75 tax on the sale of every vaccine. The money goes into a fund that provides payments to adults and children who inevitably suffer the rare side effects of vaccines, while protecting pharmaceutical companies from vaccine injury lawsuits.
Over $70 Million Paid in SIRVA Lawsuits Since 2011
The VICP has paid out around $70 million dollars to over 500 people who develop SIRVA after receiving vaccines since 2011.
SIRVA Lawsuit Settlements
The average payout for a SIRVA lawsuit settlement is around $140,000, but the maximum payout is $250,000 for pain, medical costs, and disability.